Better Home Adopts Poison Pill to Block Founder's Board Takeover, Stock Drops 12%
BETR is trading near its 52-week low of $11.431 (0.5% above the low).
Summary
Better Home & Finance adopted a limited-duration shareholder-rights plan (poison pill) with a 15% trigger, directly aimed at thwarting founder and former CEO Vishal Garg's attempt to regain control. The stock fell about 12% to $11.52, touching a 52-week low of $11.50, as the market reacted negatively to the escalating boardroom battle. This follows a week of intense proxy warfare: Garg launched a consent solicitation to remove five directors, Activant Capital joined the effort, and the company filed a lawsuit against Garg alleging securities law violations. The poison pill is a defensive move that could dilute any hostile accumulation above 15%, but it also signals deep governance dysfunction and may deter potential acquirers or strategic investors. The plan expires at the 2027 annual meeting, giving the board time to resolve the dispute, but the immediate risk is further stock pressure as the proxy fight continues.
At the time of this announcement, BETR was trading at $11.49 on NASDAQ in the Finance sector, with a market capitalization of approximately $218.3M. The 52-week trading range was $11.43 to $94.06. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.